188 related articles for article (PubMed ID: 8942815)
1. Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients.
Kelly SL; Lamb DC; Kelly DE; Loeffler J; Einsele H
Lancet; 1996 Nov; 348(9040):1523-4. PubMed ID: 8942815
[No Abstract] [Full Text] [Related]
2. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
[TBL] [Abstract][Full Text] [Related]
3. Antifungal susceptibility testing of Candida albicans by flow cytometry.
Gökahmetoglu S; Nedret Koç A; Patiroglu T
Mycoses; 2003 Sep; 46(8):307-11. PubMed ID: 12950899
[TBL] [Abstract][Full Text] [Related]
4. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
[TBL] [Abstract][Full Text] [Related]
5. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Jandourek A; Brown P; Vazquez JA
Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
[No Abstract] [Full Text] [Related]
6. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.
Khan ZU; Al-Sweih NA; Ahmad S; Al-Kazemi N; Khan S; Joseph L; Chandy R
J Clin Microbiol; 2007 Jun; 45(6):2025-7. PubMed ID: 17428940
[TBL] [Abstract][Full Text] [Related]
7. Identification of an amphotericin B resistant strain of Candida albicans using a rapid 3H-glucose incorporation microassay.
Sweeney JF; Greene JN; Hiemenz JW; Wei S; Rosemurgy AS; Djeu JY
J Infect; 1996 Nov; 33(3):221-6. PubMed ID: 8945714
[TBL] [Abstract][Full Text] [Related]
8. Clearance of a fluconazole-resistant Candida albicans strain after switching antifungal therapy and initiation of triple therapy for HIV infection.
Ruhnke M; Adler A; Müller FM
Clin Microbiol Infect; 2000 Apr; 6(4):220-3. PubMed ID: 11168112
[No Abstract] [Full Text] [Related]
9. Increasing resistance of Candida albicans to fluconazole.
Oldfield EC
Am J Gastroenterol; 1995 Jul; 90(7):1182. PubMed ID: 7611229
[No Abstract] [Full Text] [Related]
10. [In vitro susceptibility of Candida strains to fluconazole and amphotericin B].
Fernández Andreu CM; Martínez Machin G; Illnait Zaragozi MT; Perurena Lancha MR; Aguila Sánchez A; Galloso Brito M
Rev Cubana Med Trop; 2007; 59(2):113-8. PubMed ID: 23427444
[TBL] [Abstract][Full Text] [Related]
11. Analysis by pulsed-field gel electrophoresis of Candida albicans that developed resistance during antifungal therapy.
Mori T; Matsumura M; Oguri T
Nihon Ishinkin Gakkai Zasshi; 1998; 39(4):229-33. PubMed ID: 9795269
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
[TBL] [Abstract][Full Text] [Related]
13. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
[TBL] [Abstract][Full Text] [Related]
14. Fluconazole and amphotericin-B resistance are associated with increased catalase and superoxide dismutase activity in Candida albicans and Candida dubliniensis.
Linares CE; Giacomelli SR; Altenhofen D; Alves SH; Morsch VM; Schetinger MR
Rev Soc Bras Med Trop; 2013; 46(6):752-8. PubMed ID: 24474018
[TBL] [Abstract][Full Text] [Related]
15. Susceptibilities of Candida species to amphotericin B and fluconazole: the emergence of fluconazole resistance in Candida tropicalis.
Yang YL; Ho YA; Cheng HH; Ho M; Lo HJ
Infect Control Hosp Epidemiol; 2004 Jan; 25(1):60-4. PubMed ID: 14756222
[TBL] [Abstract][Full Text] [Related]
16. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
17. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
Khan MS; Malik A; Ahmad I
Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200
[TBL] [Abstract][Full Text] [Related]
18. [Changes in epidemiology of opportunistic infections due to Candida].
Odds FC
Rev Clin Esp; 1995 Oct; 195 Suppl 3():1-3. PubMed ID: 9441300
[No Abstract] [Full Text] [Related]
19. Unfortunate in vitro selection of resistant Candida albicans with severe clinical consequences.
Joly V; Carbon C
Clin Infect Dis; 1998 Oct; 27(4):692-4. PubMed ID: 9798017
[No Abstract] [Full Text] [Related]
20. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
Kutsyk RV; Pavliuk TD
Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
